On 30 May 2016

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May 2016, to consider and approve the Quarterly / Yearly Audited Financial Results for the aforesaid Quarter / Year end and to consider recommendation of Dividend, if any on the Equity Shares of the Company.

Powered by Capital Market - Live News

More From This Section

First Published: May 19 2016 | 5:35 PM IST

Next Story